首页> 美国卫生研究院文献>BMC Gastroenterology >Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease

【2h】

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease

机译：粪便钙卫蛋白是克罗恩病中最能区分缓解与内镜活动程度不同的生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Clinical characteristics of patients with Crohn’s disease and the control group

机译：克罗恩病患者和对照组的临床特征

著录项

期刊名称 BMC Gastroenterology
作者
Francisco Guilherme Cancela e Penna; Rodrigo Macedo Rosa; Pedro Ferrari Sales da Cunha; Stella Cristina Silva de Souza; Maria de Lourdes de Abreu Ferrari;
展开▼
作者单位

展开▼
年(卷),期 2020(20),-1
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒 ; 肝及胆疾病 ; 肠疾病 ;
关键词
Faecal calprotectin; Crohn’s disease; Simple endoscopic score for Crohn’s disease - SES-CD; C-reactive protein;

机译：粪便钙卫蛋白;克罗恩氏病;克罗恩氏病的简单内镜评分-SES-CD;C反应蛋白;

相似文献

外文文献
中文文献
专利

1. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease [J] . Francisco Guilherme Cancela e Penna, Rodrigo Macedo Rosa, Pedro Ferrari Sales da Cunha, BMC Gastroenterology . 2020 ,第1期

机译：粪便钙普罗茨蛋白是最佳区分克罗恩病中不同程度的内窥镜活动的生物标志物
2. Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease [J] . Dreesen Erwin, Berends Sophie, Laharie David, British Journal of Clinical Pharmacology . 2021 ,第1期

机译：克罗恩病患者粪便抑制，粪便冲击，粪便冲击素和内镜缓解关系的建模
3. Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publications [J] . Le Tilly Olivier, Bejan-Angoulvant Theodora, Paintaud Gilles, British Journal of Clinical Pharmacology . 2021 ,第3期

机译：德莱森等人。关于他们的文章“毛细血管暴露，粪便抗癌素，患者患者内镜缓解患者的关系的建模” - 富胎巴比人群药代动力学造型出版物的全面综述
4. A new concept of inducing remission in Crohn's disease: anti-interleukin-2-receptor antibody and mycophenolate mofetil [C] . M. LYONS, R. GANSCHOW, A. VENZKE, Falk Symposium . 2002

机译：克罗恩疾病中诱导缓解的新概念：抗白细胞介素-2-受体抗体和霉酚酸酯
5. Efficacy of Pharmacological Agents on The Remission Induction and Maintenance of Crohn’s Disease [D] . Farooq, Jeffrey 2019

机译：药理剂对克罗恩病减产和维持的疗效
6. Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence [O] . Pierre Baillet, Guillaume Cadiot, Marion Goutte, 2018

机译：粪便钙卫蛋白和磁共振成像检测克罗恩病内镜术后复发
7. Letter to Dreesen et al. on their article “Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease”—A comprehensive review of infliximab population pharmacokinetic modelling publications [O] . Olivier Le Tilly, Theodora Bejan‐Angoulvant, Gilles Paintaud, 2020

机译：德莱森等人的信。关于他们的文章“毛细血管曝光，粪便抗突素，患有克罗恩病患者内镜缓解的关系的建模” - 富胎动力学建模出版物的全面综述

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease

摘要

著录项

相似文献

相关主题

期刊订阅